Advertisement

Topics

Talecris Biotherapeutics, Inc. and The Alpha-1 Foundation Company Profile

09:45 EST 22nd November 2017 | BioPortfolio


News Articles [824 Associated News Articles listed on BioPortfolio]

Apic Bio seeded with $1mm

Gene therapy company Apic Bio Inc. spun off from the University of Massachusetts and was seeded with $1mm from the venture philanthropy arm of the Alpha-1 Foundation and private investor Ed Krapels, w...

Horizon Discovery, Michael J. Fox Foundation partner

Horizon Discovery, a global provider of gene editing and gene modulation technologies, in partnership with The Michael J. Fox Foundation for Parkinson’s Research (MJFF), introduced two new gen...

Pharnext stellt PLEODRUG PXT3003 auf dem Annual Patient-Centered Summit der Hereditary Neuropathy Foundation (HNF) vor

Pharnext SA (FR0011191287 ALPHA) (Paris: ALPHA), ist ein biopharmazeutisches Unternehmen und Pionier eines neuen Ansatzes zur Entwicklung innovativer Medikamente auf Basis der Kombination und Neup...

Pharnext's PLEODRUG PXT3003 to be Featured at the Upcoming Hereditary Neuropathy Foundation (HNF) Annual Patient-Centered Summit

Regulatory News: Pharnext SA (FR0011191287 ALPHA) (Paris:ALPHA), a biopharmaceutical company pioneering a new approach to the development of innovative drugs based on the combination and repositio...

X-ray Study Explains How Takinib Inhibits TNF-alpha

Takinib, a selective TAK1 inhibiting drug, has been shown to broaden the therapeutic efficacy of TNF-alpha (Tumor necrosis factor-alpha) inhibition...

The Current issue of “The view from here” is concerned with Biotherapeutics.

The topic of this month’s newsletter from Drug Discovery Today is “Biotherapeutics”.

Bruker Launches the ALPHA II, the Second Generation of the World’s Most Popular Compact FTIR System for Chemical Analysis, Applied Markets and Industrial Quality Control

Bruker launch the new ALPHA II, the latest generation of the ALPHA series of compact FTIR spectrometers. The ALPHA II features fully-automated test routines for validation regarding operati...

Lion Biotechnologies changes name to Iovance Biotherapeutics

Iovance Biotherapeutics, a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, changed its corporate name from Lion Biotechnologies t...

Drugs and Medications [611 Associated Drugs and Medications listed on BioPortfolio]

Esika [Ventura Corporation (San Juan, P.R)]

ēsika 3-in-1 Pro Make Up Foundation SPF 20

Plasmanate [TALECRIS BIOTHERAPEUTICS, INC.]

Plasma Protein Fraction (Human) 5%, USPPlasmanate®

Sheer cover mineral foundation [Guthy-Renker LLC]

Sheer Cover Mineral Foundation SPF-15

Cle de peau beaute silky foundation i [SHISEIDO CO., LTD.]

CPB Silky Cream Foundation I

Cle de peau beaute foundation i [SHISEIDO CO., LTD.]

cle de peau BEAUTE Cream Foundation I

PubMed Articles [593 Associated PubMed Articles listed on BioPortfolio]

Cerebral PET glucose hypometabolism in subjects with mild cognitive impairment and higher EEG high-alpha/low-alpha frequency power ratio.

In Alzheimer's disease (AD) research, both 2-deoxy-2-((18)F)fluoro-D-glucose (FDG) positron emission tomography (PET) and electroencephalography (EEG) are reliable investigational modalities. The aim ...

TILT Biotherapeutics.

Alpha-Oxo-Ketenimines from Isocyanides and Alpha-Haloketones: Synthesis and Divergent Reactivity.

The palladium-catalyzed reaction of alpha-haloketones with isocyanides afforded alpha-oxo-ketenimines through beta-hydride elimination of the beta-oxo-imidoyl palladium intermediates. Reaction of thes...

Exercise-induced changes in EEG alpha power depend on frequency band definition mode.

In the majority of studies investigating cortical alpha oscillations the alpha frequency is defined as a fixed band thus, neglecting recommendations in the EEG literature to adjust the alpha band acco...

Alpha-Synuclein to the Rescue: Immune Cell Recruitment by Alpha-Synuclein during Gastrointestinal Infection.

Intraneuronal accumulation of misfolded alpha-synuclein in the central and peripheral nervous systems is strongly linked to Parkinson disease (PD) and other related synucleinopathies. In rare inherite...

Clinical Trials [1030 Associated Clinical Trials listed on BioPortfolio]

Alpha-1 Foundation Research Registry

The Alpha-1 Foundation Research Registry is a confidential database made up of individuals diagnosed with severe alpha-1 antitrypsin deficiency (Alpha-1) or the carrier state.

Safety and Pharmacokinetics Study of Anthrax Immune Globulin Intravenous (AIGIV)

The purpose of this study is to: - evaluate the safety profile of a single intravenous administration of AIGIV (containing either 3.5 mg/kg, 7.0 mg/kg or 14.0 mg/kg anti-PA IgG) a...

Alpha-1 Foundation DNA and Tissue Bank

This is a long-term follow-up banking protocol that collects medical information and tissue (blood, liver and lung) samples for future research; use of data and samples for research purpos...

Thymosin Alpha 1, Interferon Alpha, or Both, in Combination With Dacarbazine in Patients With Malignant Melanoma

The purpose of the study is to test safety and efficacy of different doses of thymosin alpha 1 (1.6 mg, 3.2 mg, and 6.4 mg) in combination with dacarbazine and with or without Interferon a...

The Safety and Tolerability of Alpha-1 MP In Subjects With Alpha-1-Antitrypsin (AAT) Deficiency

The purpose of this clinical study is to assess the safety and tolerability of Alpha-1 MP in adult Alpha1-antitrypsin deficient patients.

Companies [1492 Associated Companies listed on BioPortfolio]

Talecris Biotherapeutics, Inc. and The Alpha-1 Foundation

Talecris Biotherapeutics Holdings Inc.

Talecris Biotherapeutics (Nasdaq: TLCR) is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders i...

Talecris Biotherapeutics, Inc.

Talecris Biotherapeutics (Nasdaq: TLCR) is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-th...

Talecris Biotherapeutics Holdings Corp.

Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disor...

Talecris Biotherapeutics

Talecris Biotherapeutics is a new company proud to inherit a legacy of more than 60 years of providing lifesaving and life-enhancing plasma-derived therapeutic proteins. Through the assets of Bayer Bi...

More Information about "Talecris Biotherapeutics, Inc. and The Alpha-1 Foundation" on BioPortfolio

We have published hundreds of Talecris Biotherapeutics, Inc. and The Alpha-1 Foundation news stories on BioPortfolio along with dozens of Talecris Biotherapeutics, Inc. and The Alpha-1 Foundation Clinical Trials and PubMed Articles about Talecris Biotherapeutics, Inc. and The Alpha-1 Foundation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Talecris Biotherapeutics, Inc. and The Alpha-1 Foundation Companies in our database. You can also find out about relevant Talecris Biotherapeutics, Inc. and The Alpha-1 Foundation Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record